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Florianópolis, Brazil
cDepartamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Federal de Santa
Catarina (UFSC), Florianópolis, Brazil
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Abstract.
Background: Evidence has revealed an association between familial hypercholesterolemia and cognitive impairment. In
this regard, a connection between cognitive deficits and hippocampal blood-brain barrier (BBB) breakdown was found in
low-density lipoprotein receptor knockout mice (LDLr–/–), a mouse model of familial hypercholesterolemia.
Objective: Herein we investigated the impact of a hypercholesterolemic diet on cognition and BBB function in C57BL/6
wild-type and LDLr–/– mice.
Methods: Animals were fed with normal or high cholesterol diets for 30 days. Thus, wild-type and LDLr–/– mice were
submitted to memory paradigms. Additionally, BBB integrity was evaluated in the mice’s prefrontal cortices and hippocampi.
Results: A tenfold elevation in plasma cholesterol levels of LDLr–/– mice was observed after a hypercholesterolemic diet,
while in wild-type mice, the hypercholesterolemic diet exposure increased plasma cholesterol levels only moderately and
did not induce cognitive impairment. LDLr–/– mice presented memory impairment regardless of the diet. We observed BBB
disruption as an increased permeability to sodium fluorescein in the prefrontal cortices and hippocampi and a decrease on
hippocampal claudin-5 and occludin mRNA levels in both wild-type and LDLr–/– mice treated with a hypercholesterolemic
diet. The LDLr–/– mice fed with a regular diet already presented BBB dysfunction. The BBB-increased leakage in the
hippocampi of LDLr–/– mice was related to high microvessel content and intense astrogliosis, which did not occur in the
control mice.
Conclusion: Therefore, LDLr–/– mice seem to be more susceptible to cognitive impairments and BBB damage induced by
exposure to a high cholesterol diet. Finally, BBB disruption appears to be a relevant event in hypercholesterolemia-induced
brain alterations.
Keywords: Blood-brain barrier, familial hypercholesterolemia, LDLr–/– mice, memory impairment, mild cognitive impair-
ment, neuroinflammation
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INTRODUCTION
Cholesterol is an important cell membrane com-
ponent, as well as a precursor of bile acids and
steroid hormones, making it essential to all ani-
mal life [1]. However, hypercholesterolemia, the
term for an increase in blood cholesterol levels,
is a well-documented risk factor for cardiovascu-
lar diseases of atherosclerotic origin [2]. Familial
hypercholesterolemia (FH), a genetic form of hyperc-
holesterolemia, is characterized by severely elevated
low-density lipoprotein (LDL) cholesterol levels
that lead to premature and progressive atheroscle-
rotic plaque deposition in the coronary arteries and
proximal aorta. According to population data, the
heterozygous and homozygous forms of FH affect
one in 200 and one in 300,000 people, respectively,
worldwide. FH is inherited in an autosomal dominant
way and is caused mainly by mutations in the LDL
receptor (LDLr) gene [3–5].
FH represents a unique opportunity to study the
effects of cholesterol metabolism on cognition over
time, because affected individuals are exposed to
hypercholesterolemia from early in life and carry
a dysfunction of LDLr [6, 7]. One clinical study
revealed that middle-aged individuals with FH were
more likely to exhibit abnormal cognitive functions
that meet the criteria for mild cognitive impairment
(MCI) [6]. Recent findings have reported neuropsy-
chological deficits, including memory decline, in
young FH individuals aged between 18 and 40 years
old [7]. We and others corroborated these clinical
observations when we showed that LDLr knock-
out (LDLr–/–) mice, an experimental FH mouse
model, displayed cognitive impairment [8, 9]. As
early as three months of age, the LDLr–/– mice dis-
played spatial and working memory impairments in
several behavioral tests, e.g., object location, the Mor-
ris water maze, and spontaneous alternation tasks
[9–12].
Other studies have reported that a high-cholesterol
diet induces cognitive impairment in rodent mod-
els [13–15]. It is worth noting that the impact of
the high cholesterol diet seems to be more intense
in LDLr–/– mice. A previous study reported a
higher neuroinflammatory response, i.e., glial acti-
vation and increased expression of inflammatory
cytokines/mediators, in LDLr–/– mice fed with a
high cholesterol diet than in wild-type mice fed with
the same diet [13]. A recent study suggested that
LDLr–/– mice exposed to a Western diet contain-
ing a high percentage of cholesterol, fat, and sucrose
presented impaired blood-brain barrier (BBB) trans-
port in Gd-DTPA contrast magnetic resonance
imaging (MRI) analysis, as well as neuroinflamma-
tion [15].
Also, we found that the LDLr–/– mice were more
susceptible to amyloid- peptide (A)-induced neu-
rotoxic effects. The A1–40 (i.c.v)-treated LDLr–/–
mice revealed more severe memory dysfunction,
disrupted acetylcholinesterase activity, astrogliosis,
oxidative imbalance, and cell membrane injury
within their hippocampi than identically treated wild-
type C57BL/6 mice. Interestingly, we also observed
that the LDLr–/– mice per se presented increased
BBB permeability in their hippocampi, which was
indicated as an increased aquaporin -4 (AQP-4)
immunoreactivity within this structure [10]. On
the other hand, there were no alterations on A
metabolism and content in brains of young and
middle-aged LDLr–/– mice, but an exacerbation of
neuronal apoptosis [11]. Therefore, BBB dysfunc-
tion and further neuroinflammation appear to be the
cause of neurodegeneration and consequent cognitive
decline in FH.
BBB regulates the transport of molecules into and
out of the central nervous system (CNS), which main-
tains a tight control over the chemical composition
of the neuronal milieu that is required for proper
neuronal functioning [16]. In this sense, one may sup-
pose that BBB breakdown and dysfunction caused by
hypercholesterolemia generates a neurotoxic milieu,
which contributes to cognitive impairment.
The purpose of this study was to investigate the
impact of exposure to a high cholesterol diet on
cognitive function, BBB integrity, and neuroinflam-
mation in LDLr–/– and C57BL/6 wild-type mice. We
also intended to find out more about the mechanisms
underlying BBB disruption and the implications for
cognitive dysfunction in FH. A thirty-day treatment
with a high cholesterol diet was used to exacerbate
hypercholesterolemia in the experimental animals.
METHODS
Animals
C57BL/6 wild-type and LDLr knockout
(LDLr–/–; B6.129S7- Ldlrtm1Her/J) mice founders
were purchased from Jackson Laboratory (Bar Har-
bor, ME) and were bred at Federal University of Santa
Catarina (UFSC, Florianópolis, Brazil). Animals
were maintained in groups of four to five animals per
cage, under controlled temperature (23 ± 1◦C) and a
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12 h light cycle (lights on 7:00 a.m.), with free access
to food and water. In this study, we used male three-
month-old wild-type and LDLr–/– mice divided
into four experimental groups (approximately 24 per
group), totalizing 96 animals. Procedures used in the
present study complied with the guidelines on animal
care of the local Ethics Committee on the Use of Ani-
mals (CEUA/UFSC), which follows the NIH publica-
tion “Principles of Laboratory Animal Care”. Process
Number of Ethical Committee approval: PP00948.
Experimental protocol
In order to investigate the impact of hypercholes-
terolemia on BBB integrity and neuroinflammation
and its relationship with the cognitive perfor-
mance, three-month-old male C57BL/6 wild-type
and LDLr–/– mice were fed for thirty days with a
standard (Nuvilab CR1, Nuvital; Quimtia Nutrientes
SA, Colombo, PR, Brazil) or with a hypercholes-
terolemic diet (20% fat and 1.25% cholesterol;
produced at the State University of Campinas, Camp-
inas, SP, Brazil) [9]. Afterwards, the mice were
submitted to several behavioral tests, including object
location, objection recognition, and spontaneous
alternation (independent groups of animals). One-
day after the object recognition test, mice were
food-deprived overnight, anesthetized, and the blood
was collected from the heart to determine plasma
cholesterol levels. Mice’s prefrontal cortex and hip-
pocampus were dissected to determine mRNA levels
of tight junction proteins and pro-inflammatory
molecules. In the sequence of object location test,
four or five animals in each group were perfused tran-
scardially, and an immunofluorescence staining was
performed in order to analyze the microvessels using
tomato lectin, as well as glial fibrillary acidic pro-
tein (GFAP) and AQP-4 immunoreactivity. Finally,
in another experimental set, immediately after the
spontaneous alternation test, the mice were submit-
ted to sodium fluorescein assay to evaluate the BBB
permeability. It is worth mentioning that the animals
continued to be fed with a high cholesterol diet or
regular diet until euthanasia. Figure 1A presents a
scheme of the study design and the experimental
cohorts’ organization.
Plasmatic total cholesterol levels and body mass
Total cholesterol levels were measured in the
plasma using the commercially available enzymatic
kit (Gold Analisa Diagnóstica Ltda, Minas Gerais,
Brazil) and following the manufacturer’s instructions.
The results were expressed in mg/dL. The plasma
cholesterol was analyzed in 20 animals (n = 4–5). At
the end of the feeding protocol, the body weight of
the animals was measured.
Behavioral tests
Open field
The spontaneous locomotor activity of mice was
evaluated in the open-field arena. The apparatus,
made of transparent PVC, had a white floor of
50 cm × 50 cm and transparent walls (divided by
black lines into squares of 10 cm × 10 cm), 40 cm
high. The experiments were conducted in a dimly
lit (7 lx) and sound-isolated room. Each mouse was
placed in the center of the open field, and the number
of squares crossed was registered for 5 min.
Object location test
To assess the spatial reference memory of mice,
we used the object location task, which is based
on the spontaneous tendency of rodents, previously
exposed to two identical objects, to later explore
one of the objects (replaced in a new location) for
a longer time than they explore the nondisplaced
object, providing a qualitative index of learning [17].
The n per group in this test was eight. The experi-
mental apparatus used was an open-field box (50 cm
wide × 50 cm deep×40 cm high) made of transparent
polyvinyl chloride (PVC), placed in a dimly lit (7 lx)
and sound-isolated room. Identical plastic rectangles
(4 cm high × 4.5 cm wide) were used as objects. The
protocol was based on that previously described [18].
The mice were placed in the center of the appara-
tus with two identical objects for 5 min. The objects
were placed 7 cm away from the walls of the open
field. Exploration of the objects was timed by a
stopwatch when mice sniffed, whisked, or looked
at the objects from no more than 1 cm away. After
the training phase, the mice were removed from the
apparatus for 180 min. After the inter-trial interval,
one object was moved to a new location. The time
spent exploring the objects in new (novel) and old
(familiar) locations was recorded for 5 min. All loca-
tions for the objects were counterbalanced among the
groups. After each trial, the experimental apparatus
was cleaned only with dry paper, thus ensuring that
it was saturated with the animals’ smell. In order to
analyze the cognitive performance, a location index
was calculated as previously described by Murai
et al. [17]: (Tnovel × 100)/(Tnovel + Tfamiliar) ,
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Fig. 1. Experimental protocol, physiological parameters, and cognitive function of C57BL/6 wild-type and LDLr–/– mice after normal or
high cholesterol diets. A) Experimental design: The C57BL/6 and LDLr–/– mice were exposed for thirty days to normal or high cholesterol
diet (1.25% of cholesterol). In the end, the animals were submitted to behavioral tasks and sodium fluorescein assay. The sodium fluorescein
assay was used to analyze the blood-brain barrier permeability. Afterwards, the mice’s brains were prepared for gene expression and
immunofluorescence analysis. Also, plasma total cholesterol levels and body weight were evaluated. B) Cholesterol levels. C) Body mass.
D) Locomotor activity (open field). E) A significant correlation between cholesterol levels and the total number of crossings in the open
field test. F) Recognition memory (object recognition test). G) A significant correlation between cholesterol levels and discriminatory score
(Pearson’s correlations). H) Spatial memory (object location test). I) Working memory (spontaneous alternation test). Data are expressed as
the mean ± SEM (n = 4–5 for cholesterol analysis and n = 8 for weight gain and behavioral analysis). *p < 0.05, **p < 0.01 and ***p < 0.001
compared with C57BL/6 mice fed with a normal diet, ##p < 0.01 and ###p < 0.001 compared with C57BL/6 mice fed with a high cholesterol
diet, and &p < 0.05 and &&&p < 0.001 compared with LDLr–/– mice fed with a normal diet (Two-way ANOVA followed by Duncan post-
hoc test). +p < 0.05 versus chance levels (50% of a new object or displaced object investigation in test trial and spontaneous alternations,
respectively; one-sample t-tests).
where Tnovel is the time spent exploring the dis-
placed object and Tfamiliar is the time spent
exploring the nondisplaced object [17].
Object recognition test
The object recognition task was also used to assess
hippocampal-dependent memory [19]. During the
training session, the animal was exposed to two
identical objects for 5 min. The animals were returned
to their home cages immediately after training. One
hour after the training, the animals were re-introduced
into the open field that contained one novel object
and one previously explored object. The objects were
of similar exploratory level/physical complexity and
similar size. A discriminatory index (total time spent
with the new object/total time of objects exploration)
was used to measure recognition memory [20]. The
n per group in this test was eight.
Spontaneous alternation test
The delayed spontaneous alternation test in the T
maze was used as a qualitative index of working mem-
ory in mice [10]. The experimental apparatus was
made of transparent black Plexiglass with a central
arm and two lateral arms positioned at a 90◦ angle to
the central arm. The central arm was separated from
the other two by a sliding door. Sliding doors were
placed at the entrance of each lateral arm. In the first
trial, the ‘forced-choice trial,’ either the left or right
goal arm, is blocked by lowering the guillotine door.
After the mouse has been released from the start arm,
it will negotiate the maze, eventually enter the open
goal arm, and return to the start position. The animal
will be confined for 5 s by lowering the guillotine door
of the start arm. After that, during 14 ‘free-choice’ tri-
als, the mouse can choose freely between the left and
right goal arm. After opening the guillotine door of
the start arm, the animal is free to choose between
both goal arms (all guillotine doors open). When the
mouse has entered one goal arm, the other goal arm is
closed. The mouse eventually returns to the start arm,
and the next free-choice trial starts after 5 s confine-
ment in the start arm. A session is terminated, and
the animal is removed from the maze immediately
after the 14 free-choice trials have been performed,
or 30 min have elapsed, whatever event occurs first.
During the session, the animals are never handled
by the experimenter. In order to isolate the cognitive
component, care was taken to diminish the odor cues
present by cleaning the maze with a damp sponge
before each new animal started its session, as these
cues can influence the alternation rate [10, 21]. In this
behavioral test, we used a total of 32 mice (n = 8).
Sodium fluorescein assay
The BBB permeability to low molecular weight
dye, sodium fluorescein, was evaluated in the pre-
frontal cortex and hippocampus of mice. Each mouse
was anesthetized with isoflurane and injected via
penile vein by sodium fluorescein (4%, 4 mL/kg).
After 30 min of the administration, animals were
anesthetized under ketamine and xylazine mixture
(75 and 10 mg/kg, respectively, i.p.) and perfused
through the left cardiac ventricle with 0.9% saline
solution. Followed the perfusion, brain structures
were dissected and processed for the sodium fluo-
rescein concentration analyses [22, 23]. Briefly, the
prefrontal cortex and hippocampus were diluted in
trichloroacetic acid (TCA) 7.5% (1:7 and 1:6, respec-
tively), homogenized and centrifuged at 10,000 ×g
for 10 min. Supernatants were diluted with 1:2.5
volume of 1 M phosphate buffer (TFK; pH 7.0)
before spectrophotometric determination of sodium
fluorescein (485 nm excitation/538 nm emission) flu-
orescence. Data are calculated using a calibration
curve of sodium fluorescein and reported as ng/mg
wet weight. We performed the sodium fluorescein
assay in 28 mice (n = 6–7).
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Immunofluorescence
Approximately twenty mice (n = 4–5) were deeply
anesthetized under ketamine and xylazine mixture
(75 and 10 mg/kg, respectively, i.p.) and were
perfused through the left cardiac ventricle with 0.9%
saline solution, followed by 4% paraformaldehyde
in 0.1 M phosphate-buffered saline (PBS), pH 7.4.
After perfusion, the brains were removed, post-fixed
in the same fixative solution for 24 h at room
temperature, and cryoprotected by immersion in a
30% sucrose solution in PBS at 4◦C. The brains were
then frozen by immersion in cooled isopentane and
stored in a freezer at –80◦C for later analyses. Serial
coronal sections (40 m) of the prefrontal cortex and
hippocampi were obtained with a cryostat (Leica) at
–20◦C. The free-floating sections were first blocked
using 5% horse serum (HS) diluted in PBS con-
taining 2% Triton X-100 (PBS-Tx) for 2 h at room
temperature and incubated overnight at 4◦C with
the following primary antibodies: mouse anti-GFAP
(Sigma, 1:400) and anti-AQP-4 (Santa Cruz Biotech-
nology, AQP4, 1:100) from goat in 1% HS diluted
in 0.5% PBS-Tx. After three washes in PBS, tissue
sections were incubated with anti-mouse Alexa 488
(Invitrogen, 1:400) and anti-goat Alexa 568 (Invit-
rogen, 1:400) in 1% HS diluted in 0.5% PBS-Tx for
2 h at room temperature. Hereafter, the sections were
washed three times in PBS and mounted on slides
with CC/Mount (Sigma), and covered with cover-
slips. For microvessels staining, the free-floating
sections were first incubated with 0.1 M tris-buffered
saline (TBS) containing 1% Triton X-100 for 20 min
at room temperature. Next, the sections were incu-
bated overnight at 4◦C with lectin from Lycopersicon
esculentum (tomato lectin; Sigma), 5 g/mL. After
three washes in TBS, tissue sections were incubated
with Streptavidin Alexa 568 conjugate (Invitrogen,
1:500) in TBS for 1.5 h at room temperature. Here-
after, the sections were washed three times in TBS
and mounted on slides with CC/Mount (Sigma) and
covered with coverslips. Finally, images from 8 serial
sections of each mouse prefrontal cortex (at the level
of Bregma 3.14 to 1.98 mm) and hippocampi (at the
level of Bregma –1.28 to –2.75 mm) were obtained
with a laser-scanning confocal Leica DMI6000
B Microscope. Accurately, approximately 40–50
confocal sections of 0.8 m thickness were taken
parallel to the coverslip (xy sections). All lighting
conditions and magnifications were kept constant
with an ×10 objective. After that, we performed a
Z-stack reconstruction. Image reconstruction and
fluorescence quantification of the total prefrontal
cortex and of the sum of the hippocampi CA1, CA3,
and dentate gyrus regions were performed using
ImageJ software, mostly as described [10, 24].
Isolation of RNA from brain tissues and cDNA
synthesis for real-time quantitative PCR
Animals (n = 5–7 per group, a total of 28 animals)
were anesthetized with the preparation of xylazine
10 mg/kg and ketamine 75 mg/kg, i.p., euthanized,
and the prefrontal cortex and hippocampus were
dissected. Brain regions were flash-frozen in liquid
nitrogen and kept at –80◦C until used. Total RNA
was extracted using SV Total RNA Isolation Kit
(Promega, USA), and 0.4 g of each sample was
reverse transcribed to cDNA using TaqMan RT
reagents. The reaction mixture was incubated 25◦C
for 10 min, 48◦C for 1 h, and 95◦C for 5 min. Quan-
titative real-time PCR, using the ABI 7900HT cycler
and SYBR Green Master Mix reagent, was performed
according to the manufacturer’s protocol (Applied
Biosystems). 10–100 ng of cDNA were amplified in a
total volume of 10 L. PCR reactions were conducted
using primer designed with the Primer Express ver-
sion 3.0 software (Applied Biosystems, USA). The




AT -3′ and reverse 5′- CCTTCGTGGGAGCCCT
TT -3′; interleukin (IL) IL-1 forward 5′- GATGAT
AACCTGCTGGTGTGTGA -3′ and reverse 5′- GTT
GTTCATCTCGGAGCCTGTAG -3′; IL-6 forward
5′- CGCTATGAAGTTCCTCTCTGCAA -3′ and
reverse 5′- CACCAGCATCAGTCCCAAGA -3′;
NOS-2 forward 5′- GGCAGCCTGTGAGACCTT
TG -3′ and reverse 5′- CATTGGAAGTGAAGCG
TTTCG -3′ and for ß-actin forward 5′- AAATCGT-
GCGTGACATCAAAGA -3′ and reverse 5′-
GCCATCTCCTGCTCGAAGTC -3′. Primers were
used in a final concentration of 0.5 M. The reaction
conditions were 50◦C for 2 min, then 95◦C for
10 min, followed by 40 cycles of 95◦C for 10 s
and 60◦C for 1 min. The data were analyzed using
Sequence Detection Systems (SDS) version 2.4
software (Applied Biosystems). A dissociation step
was added for SYBR Green runs. For each sample,
gene expression was quantified using a standard
curve and normalized against the expression of the
ß-actin gene [11].
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Statistical analyses
All data were expressed as the mean ± SEM. Sta-
tistical evaluation was carried out using the two-way
analysis of variance (ANOVA) with genotype and
diet as independent variables. Following significant
ANOVAs, multiple comparisons were performed
using Duncan’s post hoc test, without multiple com-
parisons adjustments. The Shapiro-Wilk normality
test was used, and data were normalized using square
root when they did not follow a normal distribu-
tion. The object recognition, object location, and
spontaneous alternation tasks were also analyzed
by one-sample t-tests to determine whether the dis-
crimination score, location index, and percentage of
alternations were different from minus 50% (i.e.,
chance level). Pearson’s correlations (r, P) were cal-
culated for associations between plasma cholesterol
total content and the total number of crossings or
discrimination score, as well as between cholesterol
levels and sodium fluorescein permeability in the
hippocampus, and content of sodium fluorescein in
the hippocampus and discrimination score (the plot
includes values from all the animals’ groups). Out-
liers were defined, and then, excluded after analysis.
The accepted level of significance for the tests was
p < 0.05. All tests were performed using the Statistic
software package (Stat-Soft Inc., Tulsa, OK, USA).
RESULTS
Plasma cholesterol levels and body weight in
LDLr–/– and wild-type mice after high
cholesterol diet
Like other research groups and we demonstrated
previously, LDLr–/– mice present a two to three-
fold increase in plasma cholesterol when maintained
on a normal diet (standard rodent diet) [9, 13, 25].
When submitted a high cholesterol diet for 30 days,
LDLr–/– mice presented with an increase around ten-
fold in their total cholesterol levels compared with
wild-type C57BL/6 mice. It is worth mentioning that
the exposure to high cholesterol diet in wild-type
mice caused a 16% increase in the plasma cholesterol
levels (moderate hypercholesterolemia) when com-
pared with wild-type mice fed with a normal diet.
The two-way ANOVA indicated significant effect
for genotype by diet interaction on total cholesterol
levels [F(1,15) = 582.30, p < 0.001] (Fig. 1B). About
body weight, the two-way ANOVA analyses revealed
no significant effect for genotype or diet (Fig. 1C).
Therefore, at the end of treatments, the weight did
not distinguish between the experimental groups.
Memory loss and increased locomotor activity in
hypercholesterolemic mice
Previous work from our laboratory and others
showed that LDLr–/– mice present higher locomo-
tor activity than normal matched-mice [12, 26]. Here,
we investigated the effect of high cholesterol diet con-
sumption on the locomotor activity of wild-type and
LDLr–/– mice, using the open-field arena. Two-way
ANOVA indicated a significant effect for genotype on
locomotor activity [F(1, 28) = 30.25, p < 0.001]. Sub-
sequent post-hoc comparisons revealed that LDLr–/–
mice performed a higher number of crossings in
the arena than control mice. When these hyperc-
holesterolemic mice were fed with a high cholesterol
diet, the number of total crossing was even higher
(Fig. 1D). Also, we observed that the levels of plasma
cholesterol were positively correlated with the total
number of crossings [R = 0.6129, p < 0.01] (Fig. 1E).
Next, we evaluated a hippocampal-dependent
memory (recognition memory) through the object
recognition test. Two-way ANOVA revealed a signifi-
cant effect for genotype on recognition memory [F(1,
28) = 34.90, p < 0.001]. Subsequent post-hoc compar-
isons demonstrated that LDLr–/– mice, regardless
of the diet, presented with memory impairment.
Unlike the wild-type mice, LDLr–/– mice did not
show any preference toward the novel object, pre-
senting a discrimination score similar to the random
chance (Fig. 1F). Furthermore, we found that levels
of blood total cholesterol were negatively correlated
with the discrimination score [R = –0.5542, p < 0.01]
(Fig. 1G).
We also assessed the spatial memory of mice using
object location task. Two-way ANOVA pointed a sig-
nificant effect for genotype on spatial memory [F(1,
28) = 15.44, p < 0.001]. Following Duncan’s test anal-
ysis showed that LDLr–/– mice exhibited spatial
memory deficits, independent of the diet. Once again,
our data showed that the LDLr–/– mice presented
with impaired memory regardless of the diet, while
C57BL/6 wild-type did not display cognitive deficits
in the object location task after the exposure to high
cholesterol diet (Fig. 1H).
Moreover, the T-maze was used to assess spon-
taneous alternation and working memory. Two-way
ANOVA indicated a significant effect for genotype
on working memory [F(1, 28) = 12.03, p < 0.01].
Subsequent Duncan’s post-hoc test pointed out that
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LDLr–/– mice fed with a normal or a high choles-
terol diet presented with working memory decline.
Only wild-type mice, regardless of the diet, presented
with a significantly higher percentage of alternations
than chance performance. In contrast, both LDLr–/–
mice groups fed with standard diet or hypercholes-
terolemic diet displayed a spontaneous alternation
index similar to the chance level (Fig. 1I).
High cholesterol diet exposure caused the loss of
BBB integrity in mice
The two-way ANOVA indicated a significant
effect for genotype [F(1,23) = 10.96, p < 0.01] and
for diet [F(1,23) = 8.18, p < 0.01] on sodium fluores-
cein permeability in the hippocampus of mice. The
subsequent post-hoc comparison revealed that the
moderate hypercholesterolemia, in the control mice,
was already associated with high permeability to
sodium fluorescein in the hippocampus. Furthermore,
the LDLr–/– mice per se presented with a significant
increase in BBB permeability. When fed with a high
cholesterol diet, LDLr–/– mice had their BBB perme-
ability to sodium fluorescein further increased within
the hippocampus (Fig. 2A).
With regard to prefrontal cortex, the two-way
ANOVA revealed a significant effect for geno-
type [F(1,24) = 7.99, p < 0.01] and for diet [F(1,
24) = 11.08, p < 0.01] on fluorescein permeability.
Subsequent post-hoc comparisons revealed increased
sodium fluorescein permeability in the prefrontal
cortex of wild-type mice exposed to a high choles-
terol diet. The LDLr–/– mice fed with a standard
diet presented with a slight increase (p = 0.09) in
sodium fluorescein permeability in this brain struc-
ture. Importantly, when exposed to a high cholesterol
diet, the BBB permeability of LDLr–/– mice was
higher than those fed with a normal diet, or even than
wild-type mice exposed also to a high cholesterol diet
(Fig. 2B).
Importantly, we observed a positive correlation
between plasma cholesterol levels and BBB perme-
ability to sodium fluorescein in the hippocampus of
animals [R = 0.5216, p < 0.01] (Fig. 2C). Also, the
BBB permeability in the hippocampus of mice was
negatively correlated with the discrimination score,
i.e., memory performance, of the mice [R = –0.5524,
p < 0.01] (Fig. 2D).
Besides, AQP-4, a bidirectional water channel
primarily expressed in perivascular astrocytic foot
processes, was also used as a putative biomarker of
BBB permeability [10] (Fig. 2E, F). The two-way
ANOVA indicated a significant effect for genotype
on AQP-4 immunoreactivity in the hippocampus
[F(1, 16) = 9.74, p < 0.01] and prefrontal cortex
[F(1,15) = 19.95, p < 0.01]. Duncan’s post-hoc test
indicated that AQP-4 content in the hippocampus of
LDLr–/– mice increased independently of the diet
(Fig. 2G). Moreover, subsequent post-hoc compar-
isons revealed a lightly increase (p = 0.09) in the
immunoreactivity of AQP-4 in the prefrontal cor-
tex of LDLr–/– mice. The LDLr–/– mice exposed
to hypercholesterolemic diet displayed enhanced
immunocontent of AQP-4 in the prefrontal cortex
when compared with control mice also exposed to
this diet (Fig. 2H).
The BBB proper composes of endothelial cells
of the cerebral microvasculature, which are inter-
connected by tight junctions that, in turn, form a
physical barrier restricting paracellular flux [27].
Thus, we evaluated the gene expression of claudin-
5 and occludin, which form the paracellular tight
junctions. The two-way ANOVA indicated a sig-
nificant effect for genotype and diet interaction on
claudin-5 [F(1, 16) = 54.69, p < 0.001] and occludin
[F(1, 16) = 16.15, p < 0.001] mRNA levels in the hip-
pocampus. The exposition to the high cholesterol
diet caused a decrease in the levels of RNAm of
tight junction’s proteins (claudin-5 and occludin) in
the hippocampus of C57BL/6 wild-type mice. Addi-
tionally, the LDLr–/– mice presented with decreased
gene expression of claudin-5 and occludin in the hip-
pocampus. Notably, when LDLr–/– mice were fed
with a high cholesterol diet, tight junction’s proteins
RNAm levels were higher than LDLr–/– mice feed-
ing normal diet, but these levels remained different
from those of control animals exposed to a normal
diet (Fig. 2I and K, respectively). By contrast, in
the prefrontal cortex, the two-way ANOVA analyses
indicated no significant effect for genotype or diet in
claudin-5 and occludin gene expression (Fig. 2J and
L, respectively).
High cholesterol diet modifies the brain
microvessels content in LDLr–/– mice
The microvessels endothelial cells were labeled
using tomato lectin from Lycopersicon esculentum
(Fig. 3A, B). The two-way ANOVA indicated a
significant effect for genotype [F(1, 15) = 17.06,
p < 0.001] on lectin-positive cells in the hippocampus
of mice. Subsequent post-hoc analysis revealed that
LDLr–/– mice, regardless of the diet, presented with
increased labeling of tomato lectin-positive areas
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Fig. 2. Effects of high cholesterol diet on blood-brain barrier (BBB) integrity of C57BL/6 wild-type and LDLr–/– mice. BBB permeability
to sodium fluorescein in the (A) hippocampus and (B) prefrontal cortex of wild-type and LDLr–/– mice fed with normal or high cholesterol
diet (n = 6–7). C) A significant correlation between cholesterol levels and permeability to sodium fluorescein in the hippocampus. D) A
Significant correlation between BBB permeability to sodium fluorescein in the hippocampus and discriminatory score (Pearson’s correlations).
Representative images of aquaporin-4 (AQP-4) content immunofluorescence analysis in the (E) hippocampus and (F) prefrontal cortex of
the animals. The serial stack of images of AQP-4 (red) immunofluorescence staining were obtained with a Leica DMI6000 B confocal
microscope. Scale bars, 150 m. Quantitation of AQP-4 immunoreactivity in the (G) hippocampus and (H) prefrontal cortex (n = 4–5). Gene
expression of tight junction’s protein, claudin-5 and occludin, in mice’s (I and K, respectively) hippocampus and (J and L, respectively)
prefrontal cortex (n = 5). Data are expressed as the mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 compared with C57BL/6 mice fed
with a normal diet, #p < 0.05 and ##p < 0.01 compared with C57BL/6 mice fed with a high cholesterol diet, and &p < 0.05 and &&p < 0.01
compared with LDLr–/– mice fed with a normal diet (Two-way ANOVA followed by Duncan post-hoc test).
compared with wild-type mice fed with a regular
diet. However, we did not observe differences in the
hippocampal content of lectin-positive cells between
LDLr–/– feeding high cholesterol diet and wild-type
fed with a high cholesterol diet (Fig. 3A, C). On
the other hand, in the prefrontal cortex, the two-way
ANOVA analyses indicated no significant effect for
genotype or diet in lectin-positive cells (Fig. 3B, D).
High cholesterol diet stimulated
neuroinflammation in mice’s brain
Increased BBB permeability leads to the migration
of monocytes across the barrier, as well as the infu-
sion of other pro-inflammatory cytokines resulting in
neuroinflammation [28]. Here, we assessed the
immune content of GFAP, used as a marker of
astrogliosis (Fig. 4A–D). The two-way ANOVA
analyses indicated a significant effect for geno-
type on GFAP immunoreactivity [F(1, 16) = 12.44,
p < 0.01] in the hippocampus of mice. Wild-type
mice fed with a high cholesterol diet presented with
increased GFAP immunoreactivity in the hippocam-
pus (p = 0.055). In agreement with our previous work
[10], LDLr–/– mice, regardless of the diet, had high
GFAP immune content (Fig. 4A, B, D). As shown
in Fig. 4B, LDLr–/– mice hippocampus displayed
pronounced astrogliosis, an overlap of astrocyte pro-
cesses, and disrupted individual astrocyte domains.
Finally, we did not find any difference in GFAP
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Fig. 3. Brain microvessels content in C57BL/6 wild-type and LDLr–/– mice after a high cholesterol diet. The series of images labeled
by tomato lectin (red) were obtained with a Leica DMI6000 B confocal microscope. Tomato lectin staining representative images of (A)
hippocampi (zoom of CA3 subfield) and (B) prefrontal cortex of mice. Scale bars = 150 m and 40 m (zoom). Quantitation of tomato
lectin-positive staining in the (C) hippocampus and (D) prefrontal cortex (n = 4–5). Data are expressed as the mean ± SEM. ∗∗p < 0.01
compared with C57BL/6 mice fed with a normal diet (Two-way ANOVA followed by Duncan post-hoc test).
content in the mice’s prefrontal cortex (Fig. 4C). It is
worth highlight that as we found few astrocytes in the
prefrontal cortex, quantification was not performed.
Taking into account that astrogliosis is associated
with the production of pro-inflammatory cytokines
(such as IL-1 and IL-6) and reactive species (e.g.,
nitric oxide), we investigated the gene expression of
proteins related to inflammation [29]. The two-way
ANOVA revealed a significant effect for geno-
type and diet interaction on IL-1 gene expression
in the prefrontal cortex of mice [F(1, 20) = 9.35,
p < 0.01]. Duncan’s test pointed out that a high
cholesterol diet caused an increase in the levels
of IL-1 mRNA in the prefrontal cortex of wild-
type mice, which not occurred in LDLr–/– mice
(Fig. 4H). Concerning the hippocampus, no differ-
ences were observed between experimental groups
(Fig. 4E).
The two-way ANOVA analysis also indicated a
significant effect for genotype on IL-6 mRNA lev-
els in the hippocampus [F(1, 20) = 9.44, p < 0.01]
and prefrontal cortex [F(1, 20) = 24.36, p < 0.001].
Subsequent post-hoc evaluation demonstrated that
LDLr–/– per se presented with lower levels of IL-
6 mRNA levels in the hippocampus (Fig. 4F) and
prefrontal cortex (Fig. 4I).
Additionally, we measured the gene expression
of NOS-2, an inducible form of nitric oxide syn-
thase. Importantly, the regulation of NOS-2 is
implicated in neuroinflammation mediated by glial
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Fig. 4. Neuroinflammation in C57BL/6 wild-type and LDLr–/– mice after a high cholesterol diet. The series of images of glial fibrillary
acidic protein (GFAP) (green) immunofluorescence staining were obtained with a Leica DMI6000 B confocal microscope. Representative
images of GFAP immunoreactivity of mice’s (A and B) hippocampus and (C) prefrontal cortex. Scale bars = (E and G) 150 m, (F) 50 m
and, (B) 20 m (zoom of CA3 subfield). Quantitation of GFAP-positive staining in the hippocampus is presented in panel D (n = 5). Gene
expression of proteins related to the brain inflammatory process, interleukin (IL) IL-1, IL-6, and NOS-2 in the (E, F, and G, respectively)
hippocampus and (H, I, and J, respectively) prefrontal cortex (n = 6) of the animals. Data are expressed as the mean ± SEM. ∗p < 0.05 and
∗∗p < 0.01 compared with C57BL/6 mice fed with a normal diet, #p < 0.05 and ###p < 0.001 compared with C57BL/6 mice fed with a high
cholesterol diet, and &p < 0.05 compared with LDLr–/– mice fed with a normal diet (Two-way ANOVA followed by Duncan post-hoc test).
cells, mainly astrocytes. In the brain, NOS-2 and
cytokines (such as IL-1) are activated by the
NF-κB pathway [30]. The two-way ANOVA indi-
cated a significant effect for genotype and diet
interaction on NO-2 gene expression in the mice’s
prefrontal cortex [F(1, 20) = 12.08, p < 0.01]. Sub-
sequent post-hoc evaluation (Duncan’s test) showed
that wild-type exposed to a high cholesterol diet
displayed a slight increase in the levels of NOS-2
mRNA in the prefrontal cortex (p = 0.06) (Fig. 4J).
The LDLr–/– mice fed with a standard diet pre-
sented with increased gene expression of NOS-2
in the prefrontal cortex. Notably, when LDLr–/–
were exposed to a hypercholesterolemic diet, the
levels of NOS-2 mRNA decreased (Fig. 4J). No
significant differences were found regarding the
NOS-2 mRNA levels in the hippocampus of mice
(Fig. 4G).
DISCUSSION
The natural history of FH patients involves the
premature development of cardiovascular diseases
associated with atherosclerosis [31]. In the last
decade, it has been discovered that FH is also
related to the emergence of cognitive impairment
in adulthood [6, 7]. In this context, we previously
reported that three-month-old LDLr–/– mice already
displayed learning and memory deficits that seemed
to be triggered by BBB dysfunction and neuroin-
flammation within the hippocampus [9, 10]. In
this study, we aimed to investigate the impact of
exposure to a high cholesterol diet for thirty days on
cognitive function and BBB integrity in wild-type
C57BL/6 and LDLr–/– mice. We also searched for
the mechanisms underpinning cognitive deficits and
BBB disruption in FH.
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As expected [32], LDLr–/– mice fed with a regu-
lar diet presented with a two- to three-fold increase
in total cholesterol levels in the plasma. It is worth
mentioning that a high cholesterol diet induced an
almost tenfold elevation in the plasma cholesterol
levels of LDLr–/– mice. In contrast, wild-type mice
manifested only a moderate increase in the blood
cholesterol levels when fed with a hypercholes-
terolemic diet. Another critical point is that a high
cholesterol diet did not cause any changes in the body
weight of both mouse strains; although the diet used
herein contained 20% of fat, it was not obesogenic.
This diet is much more related to changing cholesterol
levels due to the high concentration of cholesterol
when compared with other experimental diets. Exper-
imental studies in which C57BL/6 wild-type and
LDLr–/– mice were exposed to Western and high-fat
feeds for more extended periods observed changes
in body weight [15, 33, 34]. Western diets contain a
higher concentration of fat and a lower concentration
of cholesterol than the diet used in our study, while
the majority of high-fat diets contain more than 40%
of fat without the addition of cholesterol.
In this study, the moderate hypercholesterolemia
in wild-type mice was associated with BBB leak-
age of sodium fluorescein into the hippocampus and
prefrontal cortex. Our data accords with a study
by Ullrich et al. [35]. They observed an enhanced
immunocontent of IgG in the cortex of rats fed with
a high cholesterol diet. Furthermore, C57BL/6 wild-
type mice exposed to a Western diet also presented
with an increased BBB transport observed in MRI
analysis [15].
Our data showed that BBB dysfunction was also
observed in the brain structures of LDLr–/– mice
fed with a normal diet. In contrast, Rutkowsky and
collaborators [15] observed increased BBB trans-
port in LDLr–/– mice only when they were exposed
to a Western diet. Sodium fluorescein is a small
molecule that can be detected in brain areas at
extremely low concentrations. The spectrophotomet-
ric measurement of sodium fluorescein injected via
peripheral infusion is an overly sensitive method of
evaluating BBB permeability. It has been suggested
that an increased transport of sodium fluorescein
across the BBB appears to be the most sensitive
indicator of the increased permeability of the BBB
[36]. In fact, the peripheral injection of dyes and
analysis of the leakage in brain tissue has been
used extensively to evaluate BBB function [36, 37].
Notably, when exposed to a high cholesterol diet, the
BBB of LDLr–/– mice leaked sodium fluorescein
more severely. Additionally, the increased suscepti-
bility of LDLr–/– mice to manifest BBB disruption
was herein demonstrated by increased staining of
AQP-4 in the animals’ hippocampi. AQP-4, which is
expressed in the feet of astrocytes, is the main water
channel in the brain. Increased AQP-4 expression is
related to brain edema and consequently, neurolog-
ical disorders pathogenesis [38, 39]. However, the
contribution of AQP-4 depends on the disease stage.
Besides water balance regulation, AQP-4 has a range
of functions in the CNS, including a role in brain
inflammation [39]. It is worth noting that BBB dis-
ruption and increased permeability in the hippocampi
and prefrontal cortices of LDLr–/– mice occurred as
early as three months of age, and it seemed to be
more intense than the BBB disturbance visualized in
the brains of wild-type mice fed with a high choles-
terol diet. We observed a positive correlation between
plasma cholesterol levels and BBB permeability to
sodium fluorescein in the mice’s hippocampi.
The BBB is extraordinarily complex and dynamic
barrier. It is composed of a network of brain endothe-
lial cells from capillaries, which present protective
features, and perivascular cells (including astrocytes)
that maintain those features. For example, brain vas-
cular endothelium presents tight junctions between
endothelial cells. The components of these tight junc-
tions, e.g., the membrane proteins claudin-5 and
occludin, are fundamental to BBB integrity and func-
tion [40–42]. Indeed, claudin-5 and occludin are the
dominant tight junctions proteins in brain areas such
as the hippocampus [43, 44], and a decreased gene
expression of these proteins is closely related to BBB
disruption [45, 46]. We observed that leakage in
the BBB of LDLr–/– mice and wild-type mice fed
with a high cholesterol diet was accompanied by a
decreased hippocampal gene expression of claudin-5
and occludin. Notably, high-cholesterol-fed LDLr–/–
mice presented higher mRNA levels of tight junc-
tion proteins than those observed in LDLr–/– mice
fed with a normal diet. One might suppose that such
upregulation in the mRNA levels of tight-junctional
proteins is a compensatory mechanism for the greater
disruption to the integrity of the endothelial barrier
observed in high-cholesterol-fed LDLr–/– mice, in
order to repair the compromised BBB. Moreover,
we also found an increased microvasculature density,
indicated by a larger number of lectin-positive cells
within the hippocampus of LDLr–/– mice, regardless
of diet. According to this, Franciosi and colleagues
[47] previously showed pathological changes in
the brain vessels of six-month-old LDLr–/– mice.
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Pathological angiogenesis correlated with BBB
breakdown was also observed in the hippocampi
of rats fed with a high-fat diet for 12 weeks [48].
Nonetheless, as we observed in the findings from
the sodium fluorescein assay (a functional test to
analyze BBB integrity), the increase in the tight junc-
tions’ mRNA levels was not enough to prevent BBB
leakage in the hippocampus. Our results suggest that
BBB plasticity is triggered during the evolution of
FH, although it was not enough to control leakage or
prevent further brain damage.
BBB integrity is critical to neuronal homeostasis
and function. The BBB separates the brain from the
periphery both physically and metabolically. It makes
the brain an “immune privileged” place [49, 50]. Sig-
nificantly, BBB dysfunction was detected in patients
with MCI and dementia [16, 51]. Herein we showed
that the BBB dysfunction in high-cholesterol-fed
wild-type mice was not associated with memory
impairment. It is important to mention some pre-
vious studies [13, 14] that used a more prolonged
period of exposure to a high cholesterol diet (at least
eight weeks), then observed memory impairments
in wild-type mice. Moreover, Machado et al. [52]
demonstrated that three-month-old C57BL/6 mice
exposed to a high cholesterol diet for 30 days did not
present with memory damage. However, the authors
also observed that the treatment of the mice with a
non-effective dose of scopolamine caused cognitive
impairment, which pointed to the possibility that prior
biochemical brain alterations made them more sus-
ceptible to memory dysfunction. In the present study,
young adult LDLr–/– mice displayed recognition,
spatial, and working memory deficits when submitted
to object recognition, object location, and sponta-
neous alternation tasks, respectively. These findings
were in line with our previous work [12, 53]. We also
found a correlation between plasma cholesterol levels
and cognitive decline, i.e., higher cholesterol levels
were related to a lower discriminatory score in the
novel object recognition task. We also observed that
increased BBB permeability in the hippocampus was
negatively correlated with the mice’s memory perfor-
mance. The BBB disruption seemed to be critically
related to hypercholesterolemia-induced cognitive
impairment.
Another behavioral alteration displayed by
LDLr–/– mice was an increase in locomotor activity,
a hyperactive phenotype [26]. Additionally, we
observed that the locomotor activity in LDLr–/–
mice was even greater when they were given a high
cholesterol diet. In fact, we observed a positive
correlation between cholesterol levels and the
total number of crossings in the open-field arena.
We speculated that the increased total number of
crossings in the open-field arena found in hyperc-
holesterolemic LDLr–/– mice was due to a lack of
spatial habituation [54, 55].
The association between BBB disruption and cog-
nitive impairment that we observed in LDLr–/– mice
was not accompanied by any alterations in cere-
bral A levels, i.e., amyloid pathology. Recently,
we showed that memory impairment in three- and
fourteen-month-old LDLr–/– mice were linked to an
exacerbation of neuronal apoptosis, without changes
in A levels, in the prefrontal cortex and hippocam-
pus [11]. Our data accord with the findings regarding
from ApoE–/– mice, another hyperlipidemia mouse
model. These mice also developed secondary neu-
rodegenerative changes after BBB breakdown in the
absence of A pathology [56]. The loss of BBB
integrity and consequent neuronal death are possi-
bly the cause of cognitive dysfunction induced by
hypercholesterolemia, mainly FH. However, it is wor-
thy of notice that diet-induced hypercholesterolemia
might be involved in a modification in A levels.
Thirumangalakudi et al. [13] demonstrated that a two-
month hypercholesterolemic diet caused an increase
in A1–40 levels, but not A1–42, in the cerebral cor-
tex of LDLr–/– mice. It is necessary to mention that
these authors did not compare the content of A
between wild type and LDLr–/– mice. Moreover,
five months’ exposure to a high cholesterol diet (5%
cholesterol) in rats led to increased A immunoreac-
tivity in the cortex [35].
The mechanisms that are involved in the con-
nection between BBB disruption and cognitive
impairments induced by hypercholesterolemia need
to be investigated further. In several diseases, neu-
roinflammation is known to link increased BBB
permeability and brain injury [57]. Many studies have
demonstrated that the extravasation of plasma con-
tent into the brain through a disrupted BBB has the
potential to cause neuroinflammation [58–60]. Also,
a leaking BBB induces neuroinflammatory responses
both by allowing peripheral inflammatory cells to
infiltrate the brain parenchyma and activating glial
cells. It is known that neuroinflammation coincides
with the vascularization of the brain [61]. Lectin-
positive cells observed herein in the hippocampi of
hypercholesterolemic mice might connote a possible
rearrangement of the hippocampal microvasculature,
allowing the infiltration of circulating cells through
the brain parenchyma and thereby initiating the
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process of neuroinflammation. Thus, a vicious cycle
is created, because that inflammation compromises
the BBB [62]. Microglia and astrocytes activation
are the main components of neuroinflammation. As
per our previous work [10], we observed intense
astrogliosis in the hippocampi of LDLr–/– mice. This
is characterized by a reduction in individual astro-
cyte domains. In this regard, we showed previously
that in vitro LDL treatment had a prominent effect on
astrocytes morphology [63]. We also reported dys-
functional hippocampal neurogenesis in young adult
LDLr–/– mice [63]. Importantly, neuroinflammation
associated with astrogliosis can alter the process of
neurogenesis [64]. Furthermore, herein, wild-type
mice fed with a high cholesterol diet also exhibited
a slight but not significant increase in hippocampal
astrocyte density.
Reactive astrocytes can release a cascade of
pro-inflammatory and neurotoxic factors including
inflammatory interleukins and reactive species, all
of which can disrupt the BBB, enhance the brain
inflammatory cascade, and cause neuronal dysfunc-
tion and death [65, 66]. Previously, we showed that
LDLr–/– mice presented with an increased level of
reactive species in their prefrontal cortices and hip-
pocampi [10]. In the present study, we observed
that LDLr–/– mice fed with a regular diet presented
an increased gene expression of NOS-2 (inducible
NOS) in their prefrontal cortices. The activity of this
isoform of NOS is related to cells’ inflammatory
response. Importantly, it is known that the production
of nitrite oxide, induced by NOS-2, is related to brain
damage associated with systemic inflammation [67].
Indeed, the regulation of the inducible NOS isoform,
highly implicated in neuroinflammatory processes
associated with glial cells, takes place at the tran-
scriptional level [68]. Herein, we also visualized that
a compensatory response in LDLr–/– mice exposed
to a hypercholesterolemic diet led to a decrease in
gene expression of NOS-2 in their prefrontal cortices.
IL-6 also plays an important part in the neu-
roinflammatory process, but this interleukin presents
significant roles in brain function. In physiological
conditions, it is involved in neural plasticity, long-
term potentiation, and memory [69]. Furthermore,
it can exert opposite actions triggering either neu-
ronal survival after injury or producing neuronal
degeneration and cell death in neurodegenerative
disorders [70]. Although IL-6 is mostly regarded
as a pro-inflammatory cytokine, other of its signal-
ing properties can induce anti-inflammatory effects,
making it a pleiotropic cytokine [71]. Herein, we
observed a significant decrease in IL-6 mRNA levels
in the hippocampi and prefrontal cortices of LDLr–/–
mice, regardless of diet. Similarly, Rutkowsky and
colleagues [15] discovered a reduction in IL-6 gene
expression in the brains of LDLr–/– mice. Given the
the dual effects of IL-6, it is not possible to con-
clude whether the observed reduction in hippocampal
IL-6 levels of LDLr–/– mice has beneficial or haz-
ardous consequences. Moreover, IL-1 is a cytokine
intimately involved in the intensification of acute
neuroinflammatory processes [72]. However, we did
not observe any alterations in the mRNA levels of
IL-1 in the hippocampi or prefrontal cortices of
LDLr–/– mice, regardless of diet. While this was
the case in Rutkowsky et al.’s study [15], Thiru-
mangalakudi et al. [13] did report an increase in the
expression of IL-1 in the hippocampus of LDLr–/–
mice. We observed a significant increase in mRNA
levels of NOS-2 and IL-1 in the prefrontal cortex of
C57BL/6 mice fed with a high cholesterol diet. The
increased permeability of the BBB in C57BL/6 wild-
type mice fed with a high cholesterol diet appeared to
be correlated with an induction of the inflammatory
molecules’ response.
Another relevant finding in our study was the
greater susceptibility of the hippocampus to the
effects of hypercholesterolemia than the prefrontal
cortex. We observed that the dysfunction in the BBB
(i.e., decreased levels of claudin-5 and occludin
mRNA levels), astrogliosis, and increased lectin-
positive cells were more evident in the hippocampi of
hypercholesterolemic mice, mainly of the LDLr–/–
strain. This is significant, because the hippocampus
is considered to be one of the most vulnerable brain
regions in the early phases of neurodegenerative
dementias, including Alzheimer’s disease [73].
Furthermore, it also seems to be more affected by
metabolic disorders. For instance, Kanoski et al. [74]
demonstrated that a high fat diet intake caused BBB
breakdown in the hippocampi of rats, but not in their
prefrontal cortices or striata. However, it is essential
to mention that we did not discard the impact of
hypercholesterolemia in the prefrontal cortex. In the
sodium fluorescein assay, we observed an increased
BBB leakage in the prefrontal cortex of hypercholes-
terolemic mice. These data are in agreement with the
damage induced by hypercholesterolemia that we
already demonstrated in this brain structure [14, 11].
Our previous data showed that Swiss mice exposed
to a high cholesterol diet presented increased
acetylcholinesterase activity in the prefrontal
cortex [14]. Additionally, we recently observed
112 J. de Oliveira et al. / BBB Disruption is More Severe in LDLr–/– Mice
Fig. 5. An illustrative scheme summarizing the main findings in C57BL/6 and LDLr–/– mice after a high cholesterol diet. The LDLr–/–
mice, which already presented increased levels of plasma cholesterol, after a high cholesterol diet exhibited severe hypercholesterolemia.
The hypercholesterolemia in LDLr–/– induced leakage of BBB was associated with intense astrogliosis, increased microvessels content, and
decreased levels of IL-6, which ultimately caused cognitive impairments. The LDLr–/– mice exposed to high cholesterol diet exhibited a
further increase in the leakage to sodium fluorescein in the hippocampus and prefrontal cortex, which was associated with an upregulation in
the gene expression of claudin-5 and occludin in the hippocampus. On the other hand, C57BL/6 mice fed with a high cholesterol diet displayed
moderate hypercholesterolemia that was also associated with BBB disruption, but not with significant induction of the neuroinflammatory
process and, therefore, did not cause alterations on cognitive function.
exacerbation of apoptosis in the prefrontal cortex of
LDLr–/– mice [11].
In summary, our results point to BBB disruption
as a critical event in brain alteration caused by diet-
induced hypercholesterolemia. Most importantly, a
greater disruption of BBB integrity was observed in
three-month-old LDLr–/– mice which, consequently,
might have played a primary role in the cognitive dys-
function already observed in young adults with FH
(Fig. 5). Finally, neuroinflammation is an important
mechanism related to BBB disturbance and cogni-
tive impairment in FH. Our study provides relevant
new data about the role of neuroinflammation and
BBB dysfunction in the onset of cognitive impair-
ment caused by hypercholesterolemia. However, the
study has some limitations with regard to the rela-
tionship and causality of these effects. More research
is needed to unravel the deep molecular mechanisms
underlying the involvement of BBB disruption and
neuroinflammation in the development of cognitive
impairment caused by hypercholesterolemia.
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